Clinical Trial Update: Effects of Angiotensin II Receptor Blocker Compared With Diuretics in High-risk Hypertensive Patients [Phase 4]

View source ↗

Summary

This report summarizes a Phase 4 clinical trial comparing an angiotensin II receptor blocker with a diuretic in high-risk patients with essential hypertension. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Angiotensin-II Receptor Blocker (angiotensin II receptor blocker)
• Diuretic (diuretic)

Snippet

Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital | Conditions: Essential Hypertension | Phase 4 | Status: UNKNOWN